Johnson & Johnson Innovation - JJDC, Inc. 13F Holdings · last filed Q2 2021
Johnson & Johnson Innovation - JJDC, Inc. reported 21 securities worth $978.19M in its SEC 13F filing for Q2 2021 (period ended 2021-06-30). Top holdings: FATE (29.98%), ARWR (27.61%), PTGX (11.24%). Among its top 25 positions this quarter: 4 new, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | FATE | FATE THERAPEUTICS, INC. | $293.3M | 29.98% | 3.4M | Hold |
| 2 | ARWR | ARROWHEAD PHARMACEUTICALS | $270.1M | 27.61% | 3.3M | Hold |
| 3 | PTGX | PROTAGONIST THERAPEUTICS INC. | $109.9M | 11.24% | 2.4M | Hold |
| 4 | CVRX | CVRX, INC. | $97.9M | 10.01% | 3.5M | New |
| 5 | LEGN | LEGEND BIOTECH CORPORATION | $66.9M | 6.84% | 1.6M | Hold |
| 6 | MGTX | MEIRAGTX HOLDINGS PLC | $44.9M | 4.59% | 2.9M | Hold |
| 7 | FUSN | FUSION PHARMACEUTICALS INC. | $29.7M | 3.03% | 3.7M | Hold |
| 8 | VOR | VOR BIOPHARMA, INC. | $20.0M | 2.05% | 1.1M | Hold |
| 9 | PHGE | BIOMX INC. | $11.6M | 1.19% | 2.1M | Hold |
| 10 | PNT | THERAPEUTICS ACQUISITION COR | $10.3M | 1.05% | 1.0M | New |
| 11 | ACET | ADICET BIO, INC. | $7.5M | 0.77% | 728,944 | Hold |
| 12 | PHASQ | PHASEBIO PHARMACEUTICALS, INC. | $6.0M | 0.61% | 1.6M | Hold |
| 13 | ALDX | ALDEYRA THERAPEUTICS, INC. | $4.5M | 0.46% | 394,834 | Hold |
| 14 | CSLT | CASTLIGHT HEALTH INC. | $2.1M | 0.22% | 811,295 | Hold |
| 15 | NPCE | NEUROPACE, INC. | $1.3M | 0.13% | 55,435 | New |
| 16 | ZY | ZYMERGEN INC. | $662,000 | 0.07% | 16,553 | New |
| 17 | TCON | TRACON PHARMACEUTICALS, INC. | $545,000 | 0.06% | 84,003 | Hold |
| 18 | CBIO | CATALYST BIOSCIENCES, INC. | $290,000 | 0.03% | 66,951 | Hold |
| 19 | GRAY | GRAYBUG VISION, INC. | $269,000 | 0.03% | 49,547 | Hold |
| 20 | LUNG | PULMONX CORPORATION | $249,000 | 0.03% | 5,639 | Hold |
| 21 | SENS | SENSEONICS HOLDINGS, INC. | $210,000 | 0.02% | 54,621 | Trimmed |
Source: SEC Form 13F filings · as of 2021-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR